Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Sharon Cohen, MD, FRCPC, faculty for this educational event, received research grants paid to institution from AbbVie, AgeneBio, Alector, Alnylam, Alzheon, Anavex, Biogen, Cassava Sciences, Eisai, Eli Lilly, GAP, Green Valley, Janssen, Novo Nordisk, RetiSpec, Roche, UCB Biopharma, and Vielight; and received consulting fees from Alnylam, Alzheimer's Society Toronto, Biogen, Cassava Sciences, Cognivue, Cogstate, Conference Board of Canada, Coverage Policy Task Force (CFPT) Alliance for Aging Research, Eisai, Eli Lilly, INmune Bio, Lundbeck, Novo Nordisk, Ontario Dementia Care Alliance (ODCA), Parexel, proMIS Neurosciences, RetiSpec, Roche, SciNeuro Pharmaceuticals, Seq Biomarque, and Voices of Alzheimer's (VoA).
Richard S. Isaacson, MD, faculty for this educational event, received consulting fees from Acadia, and Novo Nordisk.
Marwan Noel Sabbagh, MD, FAAN, faculty for this educational event, received research grants from Biogen, and Janssen; received ownership interest from NeuroTau, uMethod Health, Athira, Seq BioMarque, NeuroReserve, Lighthouse Pharmaceuticals, Alzheon, and Reservoir Neuroscience; and received consulting fees from Roche-Genentech, Eisai, Lilly, Synaptogenix, NeuroTherapia, T3D, Signant Health, Novo Nordisk, Corium, Prothena, and KeiferRx.
Facebook Comments